http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6472159-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0fef8b7af1d2d5e5bbad7ad023c8a2fb
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2730-10134
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 1999-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460e11c66946b7c1151231de19546b8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d23ae8a1a7ea03e786a861330f2fbe0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cef3395919a3bf501b300468e7a006e
publicationDate 2002-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-6472159-B1
titleOfInvention Use of an amphipathic compound for providing an adjuvant to a subunit vaccine
abstract The present invention provides a method of inducing an immune response to a subunit antigen in a non-responding subject by administering to the subject a composition comprising the subunit antigen and an amphipathic compound. A preferred antigen is a hepatitis B antigen, and a preferred amphipathic compound is DC-chol.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10232052-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077184-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011070298-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11717563-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105435-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010203116-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11235069-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9498493-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010209452-A1
priorityDate 1998-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9640067-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5283185-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115234
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54236888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421150522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415814548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128119512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420298565
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129047202
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66053
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127739541
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID111262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449782971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16219102

Total number of triples: 53.